Related Experiment Video
Updated: Jun 23, 2026
09:51
Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
Titanium particles modulate expression of Toll-like receptor proteins
Jukka Pajarinen1, Zygmunt Mackiewicz, Raimo Pöllänen
1Department of Medicine (Rheumatology), Institute of Clinical Medicine, Biomedicum Helsinki, University of Helsinki, Finland.
Journal of Biomedical Materials Research. Part A
|May 9, 2009
Summary
Titanium particles downregulate Toll-like receptors (TLRs) in joint replacements, potentially reducing inflammation but increasing infection risk. This study investigated TLRs in particle-induced inflammation models.
Area of Science:
- Biomedical Engineering
- Immunology
- Orthopedic Surgery
Background:
- Aseptic loosening of joint replacements is a significant clinical challenge.
- The role of Toll-like receptors (TLRs) in this process remains unclear.
- Titanium (Ti) particles are common wear debris from implants.
Purpose of the Study:
- To investigate the effect of Ti particles on TLR expression in a murine model of particle-induced inflammation.
- To determine if Ti particles modulate TLR protein and mRNA levels.
Main Methods:
- A murine model using intramedullary stainless steel rods with and without Ti particles was established.
- Femur sections were analyzed for TLR1, 2, 4, 5, 8, and 9 protein expression via immunohistochemistry at 2 and 10 weeks.
- RAW 264.7 cells were stimulated with Ti particles to assess TLR4 mRNA levels.
Main Results:
- A decrease in TLR immunoreactive cells was observed between 2 and 10 weeks post-implantation in both groups.
- Ti particles significantly reduced the number of TLR immunoreactive cells compared to the rod-only group at both time points.
- In vitro, Ti particles downregulated TLR4 mRNA expression in RAW 264.7 cells.
Conclusions:
- Ti particles appear to downregulate TLR expression following an initial inflammatory phase.
- This downregulation may serve to limit excessive inflammation but could compromise immune defense against pathogens.
- Further research is needed to understand the long-term implications of TLR modulation by implant debris.
More Related Videos
Related Concept Videos
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...